Sanofi Ends Research Into 2 Experimental Zika Vaccines After U.S. Funding Focus Shifts

Wall Street Journal: Sanofi Stops Work on Two Zika Vaccines
“Drugmaker Sanofi SA has ended its development of two Zika virus vaccines, citing a decline in new infections and limits on U.S. government funding, in a move that illustrates the challenges in sustaining research in emerging infectious diseases after major outbreaks subside…” (Loftus, 9/6).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.